Helping people gain better

control of their health

News

Study published in JAMA Network by Lindsay Harrison, MD

Posted on June 13, 2016

Effect of Adding Liraglutide vs Placebo to a High-Dose lnsulin Regimen in Patients With Type 2 Diabetes: A Randomized Clinical Trial

Liraglutide added to high-dose insulin therapy improved glycemic control, decreased body weight, and enhanced treatment satisfaction in this difficult-to-treat patient population with high-dose insulin requirements. Further studies are warranted to confirm these findings and evaluate the long-term risk and benefit of this treatment option.  Read more at: http://archinte.jamanetwork.com/article.aspx?articleid=2526669